Eledon Pharmaceuticals, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Eledon Pharmaceuticals, Inc. (ELDN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 27.59 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Eledon Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 10.95M shares, a 58.79% increase year-over-year.
- Eledon Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 6.90M shares, a 79.82% decline year-over-year.
- Eledon Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 34.17M shares, a 233.79% increase year-over-year.
- Eledon Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 10.24M shares, a 23.11% increase year-over-year.
- Eledon Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.33M shares, a 94.57% decline from fiscal 2024.
- Eledon Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 24.58M shares, a 26.61% decline from fiscal 2023.
- Eledon Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 33.49M shares, a 311.42% increase from fiscal 2022.
- Eledon Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 8.14M shares, a 648.65% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 27.59M shares 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | 10.95M shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 1.33M shares 10-K · filed 2026-03-19 | |||||||
| 2025-09-30 | 7.37M shares 10-Q · filed 2025-11-14 | |||||||
| 2025-06-30 | 10.50M shares 10-Q · filed 2026-08-13 | |||||||
| 2025-03-31 | 6.90M shares 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | 24.58M shares 10-K · filed 2026-03-19 | |||||||
| 2024-09-30 | 41.47M shares 10-Q · filed 2025-11-14 | |||||||
| 2024-06-30 | 33.79M shares 10-Q · filed 2025-08-14 | |||||||
| 2024-03-31 | 34.17M shares 10-Q/A · filed 2025-08-14 | |||||||
| 2023-12-31 | 33.49M shares 10-K/A · filed 2025-08-14 | |||||||
| 2023-09-30 | 40.18M shares 10-Q · filed 2024-11-12 | 33.70M shares 10-Q · filed 2023-11-09 | ||||||
| 2023-06-30 | 25.26M shares 10-Q · filed 2024-08-19 | |||||||
| 2023-03-31 | 10.24M shares 10-Q/A · filed 2024-08-19 | 10.24M shares 10-Q · filed 2023-05-11 | ||||||
| 2022-12-31 | 8.14M shares 10-K/A · filed 2024-08-19 | 8.14M shares 10-K · filed 2023-03-30 | ||||||
| 2022-09-30 | 8.22M shares 10-Q · filed 2023-11-09 | |||||||
| 2022-06-30 | 8.32M shares 10-Q · filed 2023-08-10 | 8.32M shares 10-Q · filed 2022-08-11 | ||||||
| 2022-03-31 | 8.32M shares 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | 1.09M shares 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | 674.29K shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 654.23K shares 10-Q · filed 2022-08-11 | 5.09M shares 10-Q · filed 2021-08-12 | ||||||
| 2021-03-31 | 119.54K shares 10-Q · filed 2022-05-12 | 4.66M shares 10-Q · filed 2021-05-14 | ||||||
| 2020-12-31 | 632.54K shares 10-K · filed 2022-03-24 | 3.96M shares 10-K · filed 2021-03-31 | ||||||
| 2020-09-30 | 1.83M shares 10-Q · filed 2021-11-12 | |||||||
| 2020-06-30 | 457.44K shares 10-Q · filed 2021-08-12 | 9.48M shares 10-Q · filed 2020-08-14 | ||||||
| 2020-03-31 | 528.66K shares 10-Q · filed 2021-05-14 | 9.52M shares 10-Q · filed 2020-05-15 | ||||||
| 2019-12-31 | 487.27K shares 10-K · filed 2021-03-31 | 8.77M shares 10-K · filed 2020-03-17 | ||||||
| 2019-09-30 | 487.27K shares 10-Q · filed 2020-11-16 | 8.77M shares 10-Q · filed 2019-11-13 | ||||||
| 2019-06-30 | 8.23M shares 10-Q · filed 2020-08-14 | |||||||
| 2019-03-31 | 1.24M shares 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | 974.82K shares 10-K · filed 2020-03-17 | |||||||
| 2018-09-30 | 975.88K shares 10-Q · filed 2018-11-13 | 1.39M shares 10-Q · filed 2019-11-13 | 930.83K shares 10-Q · filed 2018-11-13 | |||||
| 2018-06-30 | 996.98K shares 10-Q · filed 2018-08-07 | 1.52M shares 10-Q · filed 2019-08-13 | 949.20K shares 10-Q · filed 2018-08-07 | |||||
| 2018-03-31 | 816.77K shares 10-Q · filed 2019-05-14 | |||||||
| 2017-12-31 | 782.34K shares 10-K · filed 2019-03-28 | 400.74K shares 10-K · filed 2018-04-02 | ||||||
| 2017-09-30 | 710.90K shares 10-Q · filed 2018-11-13 | 462.01K shares 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | 587.82K shares 10-Q · filed 2018-08-07 | 587.82K shares 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | 58.04K shares 10-Q · filed 2018-05-11 | 1.86M shares 10-Q · filed 2017-05-03 | ||||||
| 2016-12-31 | 8.15M shares 10-K · filed 2018-04-02 | 1.90M shares 10-K · filed 2017-03-03 | ||||||
| 2016-09-30 | 337.67K shares 10-Q · filed 2017-11-08 | 337.67K shares 10-Q · filed 2017-11-08 | 2.12M shares 10-Q · filed 2016-11-03 | |||||
| 2016-06-30 | 347.61K shares 10-Q · filed 2017-08-09 | 347.61K shares 10-Q · filed 2017-08-09 | 2.95M shares 10-Q · filed 2016-08-04 | |||||
| 2016-03-31 | 3.07M shares 10-Q · filed 2017-05-03 | |||||||
| 2015-12-31 | 2.90M shares 10-K · filed 2017-03-03 | |||||||
| 2015-09-30 | 2.36M shares 10-Q · filed 2015-11-10 | |||||||
| 2015-06-30 | 2.35M shares 10-Q · filed 2015-08-12 | |||||||
| 2015-03-31 | 2.17M shares 10-Q · filed 2015-05-12 | |||||||
| 2014-12-31 | 2.20M shares 10-K · filed 2017-03-03 | |||||||
| 2014-09-30 | 2.88M shares 10-Q · filed 2015-11-10 | |||||||
| 2014-06-30 | 16.49M shares 10-Q · filed 2015-08-12 | |||||||
| 2014-03-31 | 16.19M shares 10-Q · filed 2015-05-12 | |||||||
| 2013-12-31 | 15.98M shares 10-K · filed 2016-03-10 | |||||||
| 2013-09-30 | 13.55M shares 10-Q · filed 2014-11-13 | |||||||
| 2012-12-31 | 10.37M shares 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |